The end of HIV: Still a very long way to go, but progress continues

English version České info

In an Editorial accompanying PLOS Medicine’s Special Issue on Advances in Prevention, Treatment and Cure of HIV/AIDS, Guest Editors Steven Deeks, Sharon Lewin, and Linda-Gail Bekker discuss priorities in the field and the content of the issue.

Vyšlo v časopise: The end of HIV: Still a very long way to go, but progress continues. PLoS Med 14(11): e32767. doi:10.1371/journal.pmed.1002466
Kategorie: Editorial
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002466

Souhrn

Zdroje

1. Joint United Nations Programme on HIV/AIDS. Fact sheet—Latest statistics on the status of the AIDS epidemic. http://www.unaids.org/en/resources/fact-sheet

2. Joint United Nations Programme on HIV/AIDS. 90–90–90—An ambitious treatment target to help end the AIDS epidemic. http://www.unaids.org/en/resources/documents/2017/90-90-90

3. Dunning L, Francke JA, Mallampati D, MacLean RL, Penazzato M, Hou T, et al. The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis. PLoS Med. 2017;14(11):e1002446. https://doi.org/10.1371/journal.pmed.1002446 29161262

4. Szubert AJ, Prendergast AJ, Spyer MJ, Musiime V, Musoke P, Bwakura-Dangarembizi M, et al. Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial. PLoS Med. 2017;14(11):e1002432. https://doi.org/10.1371/journal.pmed.1002432 29136032

5. Chanda MM, Ortblad KF, Mwale M, Chongo S, Kanchele C, Kumungoma N, et al. HIV self-testing among female sex workers in Zambia: A cluster randomized controlled trial. PLoS Med. 2017;14(11):e1002442. https://doi.org/10.1371/journal.pmed.1002442 29161260

6. Ortblad K, Kibuuka Musoke D, Ngabirano T, Nakitende A, Magoola J, Kayiira P, et al. Direct provision versus facility collection of HIV self-tests among female sex workers in Uganda: A cluster-randomized controlled health systems trial. PLoS Med. 2017;14(11):e1002458. https://doi.org/10.1371/journal.pmed.1002458

7. Eakle R, Gomez GB, Naicker N, Bothma R, Mbogua J, Cabrera Escobar MA, et al. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project. PLoS Med. 2017;14(11):e1002444. https://doi.org/10.1371/journal.pmed.1002444 29161256

8. Poteat T, Ackerman B, Diouf D, Ceesay N, Mothopeng T, Odette K-Z, et al. HIV prevalence and behavioral and psychosocial factors among transgender women and cisgender men who have sex with men in 8 African countries: A cross-sectional analysis. PLoS Med. 2017;14(11):e1002422. https://doi.org/10.1371/journal.pmed.1002422 29112689

9. Solomon S, McFall AM, Lucas GM, Srikrishnan AK, Kumar MS, Anand S, et al. Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis. PLoS Med. 2017;14(11):e1002460. https://doi.org/10.1371/journal.pmed.1002460

10. El-Sadr WM, Harripersaud K, Rabkin M. Reaching global HIV/AIDS goals: What got us here, won’t get us there. PLoS Med. 2017;14(11):e1002421. https://doi.org/10.1371/journal.pmed.1002421 29112691

11. McNairy ML, Lamb MR, Gachuhi AB, Nuwagaba-Biribonwoha H, Burke S, Mazibuko S, et al. Effectiveness of a combination strategy for linkage and retention in adult HIV care in Swaziland: The Link4Health cluster randomized trial. PLoS Med. 2017;14(11):e1002420. https://doi.org/10.1371/journal.pmed.1002420 29112963

12. Elul B, Lamb MR, Lahuerta M, Abacassamo F, Ahoua L, Kujawski SA, et al. A combination intervention strategy to improve linkage to and retention in HIV care following diagnosis in Mozambique: A cluster-randomized study. PLoS Med. 2017;14(11):e1002433. https://doi.org/10.1371/journal.pmed.1002433 29136001

13. Beyrer C, Wirtz AL, O’Hara G, Léon N, Kazatchkine M. The expanding epidemic of HIV-1 in the Russian Federation. PLoS Med. 2017;14(11):e1002462. https://doi.org/10.1371/journal.pmed.1002462

14. Morris L, Mkhize NN. Prospects for passive immunity to prevent HIV infection. PLoS Med. 2017;14(11):e1002436. https://doi.org/10.1371/journal.pmed.1002436 29136030

15. Mayer KH, Seaton KE, Huang Y, Grunenberg N, Isaacs A, Allen M, et al. Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial. PLoS Med. 2017;14(11):e1002435. https://doi.org/10.1371/journal.pmed.1002435 29136037

16. Boyd MA, Mocroft A, Ryom L, Monforte Ad’ A, Sabin C, El-Sadr WM, et al. Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study. PLoS Med. 2017;14(11):e1002424. https://doi.org/10.1371/journal.pmed.1002424 29112958

17. Henrich TJ, Hatan H, Bacon O, Hogan LE, Rutishauser R, Hill A, et al. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study. PLoS Med. 2017;14(11):e1002417. https://doi.org/10.1371/journal.pmed.1002417 29112956

18. Cummins NW, Rizza S, Litzow MR, Hua S, Lee GQ, Einkauf K, et al. Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study. PLoS Med. 2017;14(11):e1002461. https://doi.org/10.1371/journal.pmed.1002461